Resveratrol alleviates endometriosis via restoration of hypoxic milieu and inhibition of autoantibody deposition
Experimental Animals · 2026
DOI: 10.1538/expanim.26-0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Animals, 2026. Verfasst von Yi Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Life Science Research, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan. Hauptthemen laut MEDLINE: Endometriosis, Resveratrol, Autoantibodies, Hypoxia. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Grant-in-Aid for Scientific Research from the Ministry of education, Culture, sports, science and Technology, Program of the Network-type Joint Usage/Research Center for radiation Disaster Medical science.
Abstract (Originalsprache)
Endometriosis, a chronic disease that affects about 10% of women of reproductive age, is characterized by severe pain and growth of endometrium-like tissues outside the uteri. Although several theories have been advanced for the cause of endometriosis, no theory fully explains why endometriosis occurs. For this study, we strove to elucidate a new mechanism of endometriosis leading to establishment of a new therapeutic strategy for its treatment. In our murine endometriosis model, a marked hypoxic state was induced in the peritoneal cavity, as indicated by increased expression of HIF-1α in peritoneal exudate cells. Moreover, innate immune response, such as TLR4 and IL-1β expression, was upregulated. To restore the hypoxic milieu in endometriosis, we chose resveratrol (RSV), a natural polyphenolic compound, as a hypoxia-reducing agent. As expected, RSV administration decreased the number of HIF-1α-positive cells. Furthermore, RSV administration reduced the size and weight of endometriotic lesions significantly. However, RSV administration did not change TLR4 and IL-1β expression levels in peritoneal exudate cells. In the process of seeking mechanisms of endometriosis other than TLR4-dependent and IL-1β-dependent pathways, we detected autoantibody deposition in endometriotic lesions. In endometriotic lesions from RSV-administered mice, accumulation of autoantibodies was inhibited compared to a control group. As described herein, we proposed a new concept by which autoantibody deposition can cause endometriosis, raising the possibility of RSV as a promising therapeutic option for endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Life Science Research, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
- Department of Obstetrics and Gynecology, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan.
Förderung
- Grant-in-Aid for Scientific Research from the Ministry of education, Culture, sports, science and Technology
- Program of the Network-type Joint Usage/Research Center for radiation Disaster Medical science
Zitieren
APA
Luo, Y., Kobayashi, M., Zhang, D., Ono, Y., Yoshino, O., & Kanehira, M. (2026). Resveratrol alleviates endometriosis via restoration of hypoxic milieu and inhibition of autoantibody deposition. Experimental Animals. https://doi.org/10.1538/expanim.26-0002
Vancouver
Luo Y, Kobayashi M, Zhang D, Ono Y, Yoshino O, Kanehira M. Resveratrol alleviates endometriosis via restoration of hypoxic milieu and inhibition of autoantibody deposition. Experimental Animals. 2026. doi:10.1538/expanim.26-0002
BibTeX
@article{Luo2026,
author = {Luo, Yi and Kobayashi, Mio and Zhang, Di and Ono, Yosuke and Yoshino, Osamu and Kanehira, Masahiko},
title = {Resveratrol alleviates endometriosis via restoration of hypoxic milieu and inhibition of autoantibody deposition},
journal = {Experimental Animals},
year = {2026},
doi = {10.1538/expanim.26-0002}
}
EUVIMED